There is a pressing need to improve the understanding of safety issues during drug development and post-approval. Our interviewees this month explain their roles in efforts to enhance drug safety.

The world is facing two immediate health crises concerning drugs and vaccines: affordable and reliable access to life-sparing medicines and the safety and reliability of those medicines.

ISA recently published Safety Instrumented System Design: A Life-Cycle Approach by Paul Gruhn PE, CFSE, and Simon Lucchini, CFSE, MIEAust CPEng. In this Q&A feature, both authors highlight the focus, ...